Publication

Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study

Hagenbeek, A., Mooij, H., Zijlstra, J., Lugtenburg, P., van Imhoff, G., Nijland, M., Tonino, S., Hutchings, M., Spiering, M., Liu, R., van Tinteren, H. & Kersten, M. J., 31-Mar-2019, In : Haematologica. 104, 4, p. e151-e153 3 p.

Research output: Contribution to journalLetterAcademicpeer-review

Copy link to clipboard

Documents

  • Phase I Dose-Escalation Study Of Brentuximab-Vedotin Combined With Dexamethasone, High-Dose Cytarabine And Cisplatin, As Salvage Treatment In Relapsed/Refractory Classical Hodgkin Lymphoma

    Final publisher's version, 85 KB, PDF-document

    Request copy

DOI

  • Anton Hagenbeek
  • Hans Mooij
  • Josée Zijlstra
  • Pieternella Lugtenburg
  • Gustaaf van Imhoff
  • Marcel Nijland
  • Sanne Tonino
  • Martin Hutchings
  • Marjolein Spiering
  • Roberto Liu
  • Harm van Tinteren
  • Marie José Kersten
Original languageEnglish
Pages (from-to)e151-e153
Number of pages3
JournalHaematologica
Volume104
Issue number4
Publication statusPublished - 31-Mar-2019

View graph of relations

ID: 79459364